Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS

Dimethyl fumarate (DMF), recently approved as an oral immunomodulatory treatment for relapsing-remitting multiple sclerosis (MS), metabolizes to monomethyl fumarate (MMF) which crosses the blood–brain barrier and has demonstrated neuroprotective effects in experimental studies. We postulated that MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodi, Benedetta, Rossi, Silvia, Morando, Sara, Cordano, Christian, Bragoni, Alberto, Motta, Caterina, Usai, Cesare, Wipke, Brian T., Scannevin, Robert H., Mancardi, Giovanni L., Centonze, Diego, Kerlero de Rosbo, Nicole, Uccelli, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503882/
https://www.ncbi.nlm.nih.gov/pubmed/25920452
http://dx.doi.org/10.1007/s00401-015-1422-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503882/
https://www.ncbi.nlm.nih.gov/pubmed/25920452
http://dx.doi.org/10.1007/s00401-015-1422-3

Ejemplares similares